Condition
Doxorubicin clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Doxorubicin clinical trials that are recruiting, at sites in 8 countries (most in Australia (1), Brazil (1), Canada (1)). By phase: Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 8Countries
All recruiting trials (2)
-
Using durvalumab with chemotherapy for muscle-invasive bladder cancer
This study is testing if adding a new immune therapy called durvalumab to standard chemotherapy can help people with muscle-invasive bladder cancer before they have surgery.
-
Combining Anlotinib with Doxorubicin and Radiotherapy for Soft Tissue Sarcoma Treatment
This study is testing if combining a cancer drug called anlotinib with chemotherapy and radiation can help people with high-grade soft tissue sarcoma have better treatment results before surgery.
Related topics
Quick answers
How many Doxorubicin clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in Australia (1 trial), Brazil (1 trial), Canada (1 trial), France (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.